Immutep Stock (NASDAQ: IMMP) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.00 / 337.69K |
Day Range | - - - |
52 Wk Range | 1.58 - 3.34 |
Market Cap | $337.01M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 4.55% |
Days to Cover | 37.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immutep (NASDAQ:IMMP) through any online brokerage.
Other companies in Immutep’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Zentalis Pharma (NASDAQ:ZNTL) and Korro Bio (NASDAQ:KRRO).
Immutep has a consensus price target of $8.67.
The stock price for Immutep (NASDAQ: IMMP) is $2.32 last updated September 19, 2024 at 9:24 AM EDT.
There are no upcoming dividends for Immutep.
Immutep’s FY earnings are confirmed for Tuesday, October 1, 2024.
There is no upcoming split for Immutep.
Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.